[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 4 sources · 4 days · First seen · Last updated

Pharmaceutical drug candidate research presentations

Overview

Pharmaceutical companies are preparing to present new drug research at upcoming global medical conferences.

Onconic Therapeutics announced that its new obesity drug candidate, validated through an internal AI-based screening system, has been selected for an oral presentation at ObesityWeek 2026 in Washington, D.C. Due to conference embargo policies, specific research data and the pipeline name have not yet been disclosed.

Similarly, Huons has secured selections for two non-clinical research results to be presented as Late-Breaking Abstracts. One candidate, a gastrointestinal disease treatment, is set for presentation at UEG Week in Barcelona, while a next-generation oral obesity treatment will be presented at Obesity Week in Washington, D.C. Huons is also advancing pipelines for dry eye treatments and lung cancer candidates.

Entities

Huons · ObesityWeek 2026 · The Obesity Society · Onconic Therapeutics

Timeline

  1. [BUSINESS] 3 sources
    Huons to present non-clinical research at global medical conferences

    Huons will present non-clinical research on its gastrointestinal and oral obesity drug candidates at the UEG Week and Obesity Week global conferences later this year.

  2. [BUSINESS] 2 sources
    Onconic Therapeutics to debut new obesity drug candidate at ObesityWeek 2026

    Onconic Therapeutics will present research on a new obesity drug candidate via oral presentation at ObesityWeek 2026 in Washington, D.C., following selection for its novelty and significance.

Sources

bokuennews.com · bosa.co.kr · hin.company · thebionews.net